Modern approaches to the choice of treatment tactics in patients with cervical cancer

Currently, approaches to the choice of treatment tactics for cervical cancer have changed significantly. According to the recommendations of ESGO (2018), RUSSCO (2020), the use of a combination of surgical treatment and radiation therapy significantly increases the incidence of complications. Therefore, when planning the treatment of patients with IB1–IIA1, a combination of surgical treatment and radiation therapy should be avoided. The article presents an analysis of modern approaches to the treatment of initial, locally advanced and advanced cervical cancer. Modern approaches to organ-preserving treatment are considered, including the view from the point of view of expanding the indications for trachelectomy as part of combined treatment. The question of the expediency of using hyperthermia and indications for this type of treatment in combination with radiation therapy is considered. The author presents his own view of the problem as a whole and possible ways to solve this problem.

1. Situation with cancer care in Russia in 2016. Ed. by A.D. Kaprin, V.V. Starinskiy, G.V. Petrova. Moscow: P.A. Herzen Moscow Oncology Research Institute, 2017. 236 p. (In Russ.).

2. Nezhat C., Roman R.A., Rambhatla A., Nezhat F. Reproductive and oncologic outcomes after fertility-sparing surgery for early stage cervical cancer: a systematic review. Fertil Steril 2020;113(4):685–703. DOI: 10.1016/j. fertnstert.2020.02.003.

3. Antipov V.A., Novikova E.G., Balakhontseva O.S., Shevchuk A.S. Functional and anatomical rehabilitation after radical abdominal trachelectomy. Problemy reproduktsii = Problems of Reproduction 2010;(1):103–7. (In Russ.).

4. Chernyshova A.L., Kolomiets L.A., Krasilnikov S.E. Organsparing treatment for invasive cervical cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2011;(2):72–8. (In Russ.).

5. Lanowska M., Mangler M., Speiser D. et al. Radical vaginal trachelectomy after laparoscopic staging and neoadjuvant chemotherapy in women with early-stage cervical cancer over 2 cm: oncologic, fertility, and neonatal outcome in a series of 20 patients. Int J Gynecol Cancer 2014;24:586–93.

6. Novikova E.G. Antipov V.A., Balakhontseva O.S. First experience of using assisted reproductive technologies after radical abdominal trachelectomy. Rossiyskiy onkologicheskiy zhurnal = Russian Journal of Oncology 2012;(1):40. (In Russ.).

7. Chernyshova A.L., Kolomiets L.A., Gyunter V.E., Marchenko E.S. New surgical aspects of organ-sparing treatment in patients with invasive cervical cancer after radical trachelectomy. Voprosy onkologii = Problems in Oncology 2017;63(5):743–7. (In Russ.).

8. Chernyshova A.L., Lyapunov A.Yu., Kolomiets L.A. et al. Identification of sentinel lymph nodes during surgical treatment for cervical cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2012;(3):28–33. (In Russ.).

9. Willows K., Lennox G., Covens A. Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract 2016;3:9. DOI: 10.1186/s40661-016-0030-9.

10. Hurria A., Levit L.V., Dale W. et al. Improving the evidence base for treating older adults with cancer: american society of clinical oncology statement. J Clin Oncol 2015;33(32):3826–33. DOI: 10.1200/JCO.2015.63.0319.

11. Population of Russia up to 2030: demographic and functional prognosis. Available at: http://www. demoscope.ru/weekly/knigi/ns_09/ acrobat/glava6.pdf. (In Russ.).

12. Colombo N., Preti E., Landoni F. et al. Endometrial cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24(Suppl 6):vi33–8. DOI: 10.1093/annonc/mdt353.

13. Chernyshova A.L., Kolomiets L.A., Krasilnikov S.E. Organsparing treatment for invasive cervical cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2011;(2):72–8. (In Russ.).

14. Spirina L.V., Kondakova I.V., Usynin E.A. et al. Activity of proteasomes and level of growth factors in patients with kidney cancer, bladder cancer, and endometrial cancer. Rossiyskiy onkologicheskiy zhurnal = Russian Journal of Oncology 2010;(1):23–5. (In Russ.).

15. Yunusova N.V., Kondakova I.V., Kolomiets L.A. et al. Adipocytes and their receptors in patients with endometrial and colon cancer: association with invasion and metastasis. Voprosy onkologii = Problems in Oncology 2015;61(4):619–23. (In Russ.).

16. Chernyshova L.A., Kolomiets I.G., Sinilkin V.I. et al. Optimization of approaches to choosing an optimal surgery volume in patients with cervical cancer (role of sentinel lymph node assessment). Voprosy onkologii = Problems in Oncology 2016;62(6):807–11. (In Russ.).

17. Ribeiro R., Baiocchi G., Tsunoda A.T. et al. Uterine transposition technique: update and review. Minerva Ginecol 2019;71(1):62–71. DOI: 10.23736/S0026-4784.18.04360-5.

18. Spirina L.V., Kondakova I.V., Kolomiets L.A. et al. Activity of proteasomes and their subunits in patients with cervical hyperplasia and endometrial cancer. Opukholi zhenskoy reproduktivnoy sistemy = Tumors of Female Reproductive System 2011;(4):64–8. (In Russ.).

19. Antipov V.A., Novikova E.G., Balakhontseva O.S., Shevchuk A.S. Radical abdominal trachelectomy: technical aspects. Voprosy onkologii = Problems in Oncology 2010;56(1):36–42. (In Russ.).

20. Chernyshova A.L., Lyapunov A.Yu., Kolomiets L.A. et al. Identification of sentinel lymph nodes during surgical treatment for cervical cancer. Sibirskiy onkologicheskiy zhurnal = Siberian Journal of Oncology 2012;(3):28–33. (In Russ.).

21. Robova H. Review of neoadjuvant chemotherapy and trachelectomy: which cervical cancer patients would be suitable for neoadjuvant chemotherapy followed by fertility-sparing surgery? Current Oncol Rep 2015;19(132):656–67.

22. Willows K., Lennox G., Covens A. Fertility-sparing management in cervical cancer: balancing oncologic outcomes with reproductive success. Gynecol Oncol Res Pract 2016;3:9. DOI: 10.1186/s40661-016-0030-9.

23. Chernyshova А., Kolomiets L., Chekalkin T. et al. Fertility-sparing surgery using knitted tini mesh implants and sentinel lymph nodes: a 10-year experience. J Invest Surg. DOI: 10.1080/08941939.2020.1745965.

24. Laengsri V., Kerdpin U., Plabplueng C. et al. Маркеры рака шейки матки: эпигенетика и микроРНК. Лаборатория Мед 2018;(49):97–111. DOI: 10.1093/labmed/lmx080.

25. Wong W.L., Su X., Li X. et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Glob Health 2014;2(2):e106–16. DOI: 10.1016/S2214-109X(13)70145-1.

26. Choi Y.J., Moskowitz J.M., Myung S.K. et al. Cellular phone use and risk of tumors: systematic review and metaanalysis. Int J Environ Res Public Health 2020;17:8079.

27. Lu R., Zhao X., Li J. et al. Genomic characterisation and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet 2020;395(10224):565–74. DOI: 10.1016/S0140-6736(20)30251-8.

28. Airik R., Schueler M., Airik M. et al. SDCCAG8 interacts with RAB effector proteins RABEP2 and ERC1 and is required for hedgehog signaling. PLoS One 2016;11(5):e0156081– e0156081. DOI: 10.1371/journal.pone.0156081.

29. Ye S., Song W., Xu X. et al. IGF2BP2 promotes colorectal cancer cell proliferation and survival through interfering with RAF-1 degradation by miR-195. FEBS Lett 2016;590(11):1641–50. DOI: 10.1002/1873-3468.12205.

30. Gouazé-Andersson V., Ghérardi M.-J., Lemarié A. et al. FGFR1/FOXM1 pathway: a key regulator of glioblastoma stem cells radioresistance and a prognosis biomarker. Oncotarget 2018;9(60):31637–49. DOI: 10.18632/oncotarget.25827.